Particular qualities of genetically engineered biological drugs prescription in the treatment of juvenile rheumatoid arthritis

Бесплатный доступ

The dynamics of genetically engineered biological drugs prescription to patients with juvenile rheumatoid arthritis have been studied. The content analysis of one hundred seventy five case-records have been done, rational assortment contour of drugs of the group under review have been offered and justified.

Juvenile rheumatoid arthritis, genetically biological engineered drugs, content analysis, abc-analysis

Короткий адрес: https://sciup.org/148317799

IDR: 148317799

Статья научная